The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(3,5-dihydroxyphenyl)-1-(4-hydroxyphenyl)-1H-imidazole ID: ALA5271408
Chembl Id: CHEMBL5271408
Max Phase: Preclinical
Molecular Formula: C15H12N2O3
Molecular Weight: 268.27
Associated Items:
Names and Identifiers Canonical SMILES: Oc1ccc(-n2cnc(-c3ccc(O)c(O)c3)c2)cc1
Standard InChI: InChI=1S/C15H12N2O3/c18-12-4-2-11(3-5-12)17-8-13(16-9-17)10-1-6-14(19)15(20)7-10/h1-9,18-20H
Standard InChI Key: DSOXCZKHMMMEKK-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 268.27Molecular Weight (Monoisotopic): 268.0848AlogP: 2.66#Rotatable Bonds: 2Polar Surface Area: 78.51Molecular Species: NEUTRALHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.87CX Basic pKa: 5.02CX LogP: 2.86CX LogD: 2.84Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.62Np Likeness Score: -0.36
References 1. Ahmadi R, Ebrahimzadeh MA.. (2020) Resveratrol - A comprehensive review of recent advances in anticancer drug design and development., 200 [PMID:32485531 ] [10.1016/j.ejmech.2020.112356 ]